Global Pharma Group SRL
The score of Global Pharma Group shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -68 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Global Pharma Group's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 17,441 € | ||||
| Equity | −623,393 € | ||||
| Cash | 19,716 € | ||||
| EBITDA | 29,851 € | ||||
| Total assets | 369,993 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Global Pharma Group's financial analysis
- Solvency-168.5%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Global Pharma Group
Global Pharma Group's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0849.471.758
- VAT number
- BE0849471758
- Peppol
- Registered · 0208:0849471758 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Oct 2012
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Global Pharma Group (SRL) has been based in Hasselt since 2012, active in: activities of holding companies. For 2025, it reports a net profit of 17,441 € and equity of −623,393 €; its revenue is not published. Its solvency stands at -168.5%, below the median of its sector (55.6%).
Companies similar to Global Pharma Group
Companies in the same business, of comparable size and area, outside its group.
- NOMA'S Ventures Activities of holding companies Wervik · balance sheet 112,657 €
- Hollanders Activities of holding companies Peer · balance sheet 378,462 €
- LCON Activities of holding companies Jabbeke · balance sheet 383,498 €
- Transmaestro Activities of holding companies Diepenbeek · balance sheet 322,653 €
- Lloyd Activities of holding companies Oostkamp · balance sheet 302,125 €
- Mars17 Activities of holding companies Brasschaat · balance sheet 363,505 €
- Micant Activities of holding companies Antwerp · balance sheet 362,581 €
- Olicél Activities of holding companies Bruges · balance sheet 341,158 €
Frequently asked questions about Global Pharma Group
What is the revenue of Global Pharma Group?
Global Pharma Group files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Global Pharma Group?
In Belgium, the VAT number is the company number prefixed with BE: BE0849471758 for Global Pharma Group, if the company is VAT-registered. Its company number (CBE) is 0849.471.758.
Where is the registered office of Global Pharma Group?
According to the CBE register, the registered office of Global Pharma Group is in 3500 Hasselt.
What is the equity of Global Pharma Group?
At the close of the 2025 financial year, the equity of Global Pharma Group amounts to -623,393 €, a solvency of -168.5% of total assets.
Who manages Global Pharma Group?
The register lists 4 active mandates at Global Pharma Group. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Global Pharma Group
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →